Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAVENDER long-term observational study of dydrogesterone for endometriosis pain
PACTR202505740799199Phase 4Recruiting
- Sponsor
- Abbott Laboratories
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 7
01
Overview
Phase 4, open-label, single-arm trial of dydrogesterone in endometriosis, sponsored by Abbott Laboratories. Primary endpoint: Change in chronic pelvic pain from baseline to month 12. Started Oct 2024; status: recruiting.
02
Drugs
dydrogesterone
03
Conditions
endometriosis
Beyond the preview
Go deeper on PACTR202505740799199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202505740799199.